Latest Medical Research News and Research
Updated: 50 min 5 sec ago
Lingering hypertension is common and may go unnoticed among women who have severe pre-eclampsia during pregnancy, according to new research in the American Heart Association's journal Hypertension
A major international study shows that if cardiac arrest patients are treated like heart attack patients only, this will potentially have negative consequences on their rehabilitation and return to working life.
Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany.
A study of around 300 volunteers, conducted in Austria by MedUni Vienna in collaboration with Diagnostic Graz, convincingly shows that Magnetic Resonance Imaging is the best choice for clarifying ambiguous mammography results.
A recent study at the University of Jyväskylä has found a surprisingly high level of mental well-being among middle-aged individuals.
Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years.
A single dose of primaquine is thought to stop people with P. falciparum malaria infecting mosquitoes, which could help bring down malaria transmission. In this Cochrane Review update prepared by an international team of researchers and co-ordinated through the Cochrane infectious Diseases Group based at LSTM, the researchers added recent data to examine this question.
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.
A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists NYU Langone Health.
New research has shed light on the reasons driving doctors out of General Practice, following earlier findings that around two out of every five GPs in the South West are planning to leave direct patient care in the next five years.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.